Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David Larsen
BTIG
David Larsen
BTIG
Wall Street Analyst
★★★★☆
#308
on 13Foresight · ranked by our own returns
58%
Success Rate
+22.8%
Average Return
22 of 38 calls profitable · +15.6% vs benchmark
📈 Across the calls we could measure, roughly 58% of David Larsen's ratings turned a profit when each position was held for 1 year — averaging +22.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

74 Buy 33 Hold 0 Sell
David's Stock Coverage 35 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
SLP
Simulations Plus
 Jun 16, 2026 HOLD Buy
+89.9% avg upside
11 analysts
$18.50
1.38% Upside
 ·
HSIC
Henry Schein
 Jun 11, 2026 BUY Buy
+7.4% avg upside
25 analysts
$100.00
25.10% Upside
 +1.2%
MDLN
Medline
 Jun 09, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
$55.00
53.09% Upside
 -0.2%
TOI
Oncology Institute
 Jun 08, 2026 BUY Strong Buy
+6.2% avg upside
6 analysts
$8.00
52.03% Upside
 +0.6%
VEEV
Veeva Systems
 Jun 03, 2026 BUY Strong Buy
+54.2% avg upside
36 analysts
$340.00
121.87% Upside
 -4.3%
ASTH
Astrana Health
 Jun 02, 2026 BUY Strong Buy
+37.0% avg upside
16 analysts
$50.00
27.72% Upside
 +3.4%
HQY
Healthequity
 May 28, 2026 BUY Strong Buy
+33.4% avg upside
20 analysts
$110.00
29.12% Upside
 -5.4%
DOCS
Doximity
 May 14, 2026 HOLD Buy
+61.4% avg upside
27 analysts
 — +14.8%
DCGO
DocGo
 May 12, 2026 HOLD Buy
+415.2% avg upside
7 analysts
 — -1.7%
HCAT
Health Catalyst
 May 12, 2026 HOLD Buy
+215.1% avg upside
15 analysts
 — -19.6%
DH
Definitive Healthcare Corp
 May 11, 2026 HOLD Hold
+658.6% avg upside
19 analysts
 — -14.3%
PGNY
Progyny
 May 11, 2026 BUY Strong Buy
+11.9% avg upside
14 analysts
$30.00
14.98% Upside
 +14.9%
LFST
Lifestance Health Group
 May 08, 2026 BUY Strong Buy
+8.7% avg upside
14 analysts
$12.00
33.62% Upside
 +11.8%
LFMD
LifeMD
 May 07, 2026 BUY Strong Buy
+145.1% avg upside
13 analysts
$10.00
110.50% Upside
 -3.6%
CYRX
CryoPort
 May 05, 2026 BUY Strong Buy
-3.8% avg upside
15 analysts
$17.00
13.32% Upside
 +7.8%
AMWL
American Well
 May 05, 2026 HOLD Hold
+64.5% avg upside
15 analysts
 — +18.1%
BTSG
BrightSpring Health Services, Inc.
 May 04, 2026 BUY Strong Buy
-16.1% avg upside
18 analysts
$65.00
1.91% Downside
 +20.3%
TDOC
Teladoc
 Apr 30, 2026 HOLD Buy
+257.8% avg upside
37 analysts
 — +17.0%
OMCL
Omnicell
 Apr 28, 2026 HOLD Strong Buy
+36.0% avg upside
12 analysts
 — -5.2%
HIMS
Hims & Hers Health
 Mar 05, 2026 HOLD Buy
-27.8% avg upside
22 analysts
 — +71.1%
EVH
Evolent Health
 Feb 25, 2026 BUY Strong Buy
+121.1% avg upside
19 analysts
$8.00
78.24% Upside
 +34.4%
CCSI
Consensus Cloud Solutions
 Feb 17, 2026 BUY Buy
-12.6% avg upside
6 analysts
$40.00
17.26% Upside
 -1.4%
IQV
IQVIA Holdings
 Feb 05, 2026 HOLD Strong Buy
+34.3% avg upside
38 analysts
 — -1.4%
PIII
P3 Health Partners
 Nov 14, 2025 HOLD Buy
+1764.8% avg upside
8 analysts
 — +78.8%
AGL
Agilon Health
 Nov 04, 2025 HOLD Buy
-59.1% avg upside
26 analysts
 — +528.7%
PRVA
Privia Health Group
 Mar 05, 2025 BUY Strong Buy
+34.1% avg upside
26 analysts
$35.00
47.78% Upside
 -7.2%
BBLNF
Babylon Holdings
 Jun 23, 2023 HOLD Buy
+65549900.0% avg upside
6 analysts
 — ·
COR
Cencora
 Aug 14, 2019 HOLD Buy
+14.6% avg upside
43 analysts
 — +30.1%
CVS
CVS Health
 Aug 14, 2019 HOLD Strong Buy
+3.1% avg upside
38 analysts
 — +15.6%
CRL
Charles River Labs
 Aug 14, 2019 HOLD Strong Buy
+12.0% avg upside
34 analysts
 — +69.5%
CAH
Cardinal Health
 Nov 16, 2018 HOLD Strong Buy
-12.8% avg upside
29 analysts
$55.00
75.23% Downside
 +5.7%
ACH
Accendra Health
 Oct 31, 2018 HOLD Hold
+439.4% avg upside
17 analysts
$9.00
178.63% Upside
 -13.8%
MCK
McKesson
 May 29, 2018 HOLD Strong Buy
-2.2% avg upside
27 analysts
$160.00
78.77% Downside
 -10.2%
MDRX
Veradigm
 Jun 19, 2017 HOLD Buy
+207.0% avg upside
22 analysts
$13.00
170.79% Upside
 +2.7%
TBRG
TruBridge
 Nov 04, 2016 HOLD Hold
+14.4% avg upside
9 analysts
$25.00
4.12% Downside
 +30.6%
🔒 30 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
David Larsen — Frequently Asked Questions
How accurate are David Larsen's stock ratings?
Based on the calls 13Foresight could measure, about 58% of David's ratings were profitable over a one-year hold, with an average return of +22.8% per rating, or +15.6% versus the S&P 500. We score every analyst the same way, from historical prices.
How is David ranked on 13Foresight?
David Larsen is currently ranked #308 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on SLP, HSIC, MDLN, TOI, VEEV, ASTH, HQY, DOCS, DCGO, HCAT, DH, PGNY and 23 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.